검색어: activator (영어 - 크로아티아어)

mtp-pe is a potent activator of monocytes and macrophages.
mtp-pe je potentni aktivator monocita i makrofaga.

nicorandil is a hybrid of potassium channel activator and nitrate.
nikorandil je hibrid aktivatora kalijevih kanala i nitrata.

press the plum activator button and count slowly for 10 seconds.
pritisnite ljubičastu tipku za aktivaciju i polako brojite 10 sekundi.

rapilysin contains the active substance reteplase(a recombinant plasminogen activator).
rapilysin sadrži djelatnu tvar reteplazu (rekombinantni aktivator plazminogena).

reteplase is a recombinant plasminogen activator that catalyzes the cleavage of endogenous plasminogen to generate plasmin.
reteplaza je rekombinantni aktivator plazminogena koji katalizira cijepanje endogenog plazminogena za tvorbu plazmina.

and they do the opposite thing of the molecule i told you about before with the blue light activator channelrhodopsin .
one čine suprotnu stvar od molekule s aktivatorom plavog svjetla channelrodopsinom , o kojoj sam vam pričao ranije .

needle inspection window plum activator button do not use the pre-filled pen and call your doctor or pharmacist if the
igla prozorčić ljubičasta tipka za aktivaciju nemojte primijeniti napunjenu brizgalicu i odmah se obratite liječniku ili ljekarniku ako je

tenecteplase is a fibrin-specific plasminogen activator produced in a chinese hamster ovary cell line by recombinant dna technology.
tenekteplaza je fibrin-specifični aktivator plazminogena proizveden na staničnoj liniji jajnika kineskog hrčka tehnologijom rekombinantne dna.

if you are receiving tissue type plasminogen activator as acute treatment for blood clots, you should not be treated with ruconest at the same time.
ako primate tkivni aktivator plazminogena kao akutno liječenje protiv krvnih ugrušaka, ne biste istodobno smjeli biti liječeni ruconestom.

thus, this influencing factor acted as both an inhibitor as well as an activator for the programme, depending on the national context and resource availability.
prema tome, taj je utjecajni čimbenik djelovao kao inhibitor i kao aktivator programa, ovisno o nacionalnom kontekstu i dostupnosti resursa.

scientific literature indicates an interaction of tissue-type plasminogen activator (tpa) and c1inh containing medicinal products.
znanstvena literatura upućuje na interakcije s lijekovima koji sadrže tkivni aktivator plazminogena (tpa) i c1inh.

carglumic acid is a structural analogue of n-acetylglutamate, which is the naturally occurring activator of carbamoyl phosphate synthetase, the first enzyme of the urea cycle.
karglumatna kiselina je strukturni analog n-acetilglutamata koji je prirodan aktivator karbamoil fosfat sintetaze, prvog enzima u ciklusu ureje.

if you are allergic to defibrotide or other ingredients of this medicine (listed in section 6) if you are using other medicines to break down blood clots such as tissue plasminogen activator
ako ste alergični na defibrotid ili neki drugi sastojak ovog lijeka (naveden u dijelu 6) ako uzimate druge lijekove za razgradnju krvnih ugrušaka kao što je tkivni aktivator plazminogena.

plasminogen activator inhibitor 1 (pai-1) activity can be reduced to around zero, but rapidly normalises within two hours showing a rebound phenomenon.
aktivnost inhibitora aktivatora plazminogena 1 (pai-1) može se smanjiti na oko nule, ali ubrzo se normalizira, tijekom dva sata, pokazujući fenomen povratne sprege.

the active substance in metalyse, tenecteplase, is a modified copy of the human enzyme ‘tissue plasminogen activator’, which the body uses to break down clots.
djelatna tvar lijeka metalyse, tenekteplaza, modificirana je kopija humanog enzima „aktivatora tkivnog plazminogena”, koji tijelo koristi za razgradnju ugrušaka.

also, in vitro, defibrotide has been shown to increase tissue-type plasminogen activator (t-pa) function and decrease plasminogen activator inhibitor-1 (pai-1) activity resulting in a decrease in procoagulant activity and an increase in the fibrinolytic potential of endothelial cells.
također, pokazalo se da defibrotid in vitro povećava funkciju tkivnog aktivatora plazminogena (t-pa) i smanjuje aktivnost inhibitora aktivatora plazminogena-1 (pai-1) što rezultira smanjenjem prokoagulacijske aktivnosti i povećanjem fibrinolitičkog potencijala endotelnih stanica.